Literature DB >> 26905319

Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon.

Henry Namme Luma1, Servais Albert Fiacre Bagnaka Eloumou2, Agnes Malongue3, Elvis Temfack4, Dominique Noah Noah5, Olivier Donfack-Sontsa6, Ivo Che Ditah7.   

Abstract

INTRODUCTION: Hepatitis C virus (HCV) infection is a major public health problem, especially in resource-limited settings where many patients are diagnosed at the stage of complications. In Cameroon, where HCV is endemic, little is known about the clinical, biological, and virological profile of HCV-infected patients.
METHODS: A clinical case note review of all patients positive for antibodies against HCV diagnosed at the gastroenterology outpatient clinic of the Douala General Hospital, Cameroon, from January 2008 to December 2014, was performed.
RESULTS: A total of 524 patients were included in the study, 53% of whom were female. The mean age was 56±13 years. A history of blood transfusion and a history of scarification were the most common potential risk factors for HCV exposure, as found in 16% and 13% of the study population, respectively. Current alcohol use was found in 24% of patients. Co-infection with hepatitis B virus and HIV was 3.6% and 3.4%, respectively. Among the patients, 39% had no complaint at diagnosis; only 16% were diagnosed through a routine medical checkup. Clinically, the most common finding was hepatomegaly (26.1% of patients). Transaminases above the upper limit of normal were found in 55.2% of patients, particularly those aged >57 years (p=0.001). Genotypes 1 (43.95%), 2 (25.11%), and 4 (28.25%) were the most common. Liver cirrhosis was present in 11% of patients and hepatocellular carcinoma in 4%, the latter being more common in males (p<0.001) and in those aged >57 years (p=0.03).
CONCLUSIONS: In the gastroenterology clinic of Douala General Hospital, while almost 40% of patients who were anti-HCV antibody-positive were asymptomatic and diagnosed fortuitously, some already presented complications, including cirrhosis and hepatocellular carcinoma. There is an urgent need to put in place programs to increase awareness and diagnosis of HCV infection and to develop extensive and targeted anti-HCV treatment guidelines to improve the management of these patients in Cameroon.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Clinical; Genotype; Hepatitis C virus; Histological; Virological

Mesh:

Substances:

Year:  2016        PMID: 26905319     DOI: 10.1016/j.ijid.2016.02.013

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

1.  Hepatitis C in Cameroon: What is the progress from 2001 to 2016?

Authors:  Borris Rosnay Tietcheu Galani; Richard Njouom; Paul Fewou Moundipa
Journal:  J Transl Int Med       Date:  2016-12-30

2.  Hepatitis C Continuum of Care in a Treatment Center in Sub-Saharan Africa.

Authors:  Henry N Luma; Servais A F B Eloumou; Dominique N Noah; B Aude Eyenga; Georges Nko'Ayissi; T Sylvie Taku; Agnes Malongue; Olivier Donfack-Sontsa; Ivo C Ditah
Journal:  J Clin Exp Hepatol       Date:  2018-01-12

Review 3.  Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis.

Authors:  Jean Joel Bigna; Marie A Amougou; Serra Lem Asangbeh; Angeladine Malaha Kenne; Steve Raoul N Noumegni; Elodie T Ngo-Malabo; Jean Jacques Noubiap
Journal:  BMJ Open       Date:  2017-06-30       Impact factor: 2.692

4.  Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.

Authors:  N Y Mapoure; M N Budzi; S A F B Eloumou; A Malongue; C Okalla; H N Luma
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

5.  [Cryoglobulin and factors associated with it in patient with anti-hepatitis-C antibodies living in resource-limited countries].

Authors:  Servais Albert Fiacre Bagnaka Eloumou; Jean Pierre Nda Mefo'o; Winnie Tatiana Bekolo Nga; Gabin Ulrich Kenfack; Linus Yakana; Agnès Malongue; Cecile Okalla; Mathurin Kowo; Firmin Ankoune Andoulo; Christian Tzeuton; Marie Solange Doualla Bidja; Henry Luma Namme; Dieudonne Adiogo; Dominique Noah Noah
Journal:  Pan Afr Med J       Date:  2019-07-04

6.  Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project.

Authors:  Liza Coyer; Oudou Njoya; Richard Njouom; Tatiana Mossus; Mathurin Pierre Kowo; Frida Essomba; Alexander Boers; Roel Coutinho; Pascale Ondoa
Journal:  Trop Med Int Health       Date:  2020-07-05       Impact factor: 2.622

Review 7.  Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings.

Authors:  Zeinab Nabil Ahmed Said; Manal Hamdy El-Sayed
Journal:  World J Hepatol       Date:  2022-07-27

Review 8.  Epidemiology of viral hepatitis in the Republic of Congo: review.

Authors:  Laure Stella Ghoma Linguissi; Celine Nguefeu Nkenfou
Journal:  BMC Res Notes       Date:  2017-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.